Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'

After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have opened for Cellares, the automated cell therapy manufacturing specialist’s c | After speedrunning a series of major manufacturing milestones in the past year-and-a-half, the “biotech floodgates” have opened for Cellares, the automated cell therapy manufacturing specialist’s co-founder and CEO told Fierce Pharma Manufacturing.

Raccontata dafiercepharma.com